NCT06560684 - CROSSOVER STUDY OF ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIR | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

October 29, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions

Tenofovir

Interventions

DRUG

Oral F/TDF Pills

For 8 weeks of each study period, the participant will take the study product at least weekly prior to anticipated RAI.

DRUG

TFV rectal douche

For 8 weeks of each study period, the participant will take the study product at least weekly prior to anticipated rectal anal intercourse (RAI).

Trial Locations (8)

RECRUITING

Weill Cornell Chelsea CRS, New York

RECRUITING

University of Pittsburgh CRS, Pittsburgh

RECRUITING

Johns Hopkins University CRS, Baltimore

RECRUITING

Hope Clinic CRS, Lawrenceville

RECRUITING

Alabama CRS (Site ID# 31788), Birmingham

RECRUITING

UCLA CARE Center CRS, Los Angeles

RECRUITING

Fenway Health (FH) CRS, Boston

RECRUITING

Chapel Hill CRS (3201), Chapel Hill

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH